<HashMap><database>biostudies-literature</database><scores/><additional><submitter>He L</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>US Department of Energy</funding><funding>Dr. Miriam and Sheldon G. Adelson Medical Research Foundation</funding><funding>NIAID NIH HHS</funding><funding>Basic Energy Sciences</funding><funding>Biological and Environmental Research</funding><funding>Office of Science</funding><funding>NIH</funding><funding>NIGMS NIH HHS</funding><pagination>168650</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11297672</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>436(16)</volume><pubmed_abstract>Engineered reverse hairpin constructs containing a partial C-heptad repeat (CHR) sequence followed by a short loop and full-length N-heptad repeat (NHR) were previously shown to form trimers in solution and to be nanomolar inhibitors of HIV-1 Env mediated fusion. Their target is the in situ gp41 fusion intermediate, and they have similar potency to other previously reported NHR trimers. However, their design implies that the NHR is partially covered by CHR, which would be expected to limit potency. An exposed hydrophobic pocket in the folded structure may be sufficient to confer the observed potency, or they may exist in a partially unfolded state exposing full length NHR. Here we examined their structure by crystallography, CD and fluorescence, establishing that the proteins are folded ha</pubmed_abstract><journal>Journal of molecular biology</journal><pubmed_title>Structure and Interactions of HIV-1 gp41 CHR-NHR Reverse Hairpin Constructs Reveal Molecular Determinants of Antiviral Activity.</pubmed_title><pmcid>PMC11297672</pmcid><funding_grant_id>R01 GM129325</funding_grant_id><funding_grant_id>DE-AC02-05CH11231</funding_grant_id><funding_grant_id>R01-GM129325</funding_grant_id><funding_grant_id>R21 AI140904</funding_grant_id><funding_grant_id>1R01GM126218</funding_grant_id><funding_grant_id>R01 GM126218</funding_grant_id><funding_grant_id>P41 GM103311</funding_grant_id><funding_grant_id>P30 GM124169</funding_grant_id><funding_grant_id>P41-GM103311</funding_grant_id><funding_grant_id>R21AI140904</funding_grant_id><pubmed_authors>Weber L</pubmed_authors><pubmed_authors>Gupta S</pubmed_authors><pubmed_authors>Kristensen LG</pubmed_authors><pubmed_authors>Drouin-Allaire C</pubmed_authors><pubmed_authors>Petzold CJ</pubmed_authors><pubmed_authors>Allaire M</pubmed_authors><pubmed_authors>He L</pubmed_authors><pubmed_authors>Barbu R</pubmed_authors><pubmed_authors>Halacoglu C</pubmed_authors><pubmed_authors>McAndrew R</pubmed_authors><pubmed_authors>Gifford G</pubmed_authors><pubmed_authors>Ralston CY</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Gochin M</pubmed_authors><pubmed_authors>Li KH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structure and Interactions of HIV-1 gp41 CHR-NHR Reverse Hairpin Constructs Reveal Molecular Determinants of Antiviral Activity.</name><description>Engineered reverse hairpin constructs containing a partial C-heptad repeat (CHR) sequence followed by a short loop and full-length N-heptad repeat (NHR) were previously shown to form trimers in solution and to be nanomolar inhibitors of HIV-1 Env mediated fusion. Their target is the in situ gp41 fusion intermediate, and they have similar potency to other previously reported NHR trimers. However, their design implies that the NHR is partially covered by CHR, which would be expected to limit potency. An exposed hydrophobic pocket in the folded structure may be sufficient to confer the observed potency, or they may exist in a partially unfolded state exposing full length NHR. Here we examined their structure by crystallography, CD and fluorescence, establishing that the proteins are folded ha</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-05-29T17:15:52.816Z</modification><creation>2026-04-08T05:29:38.184Z</creation></dates><accession>S-EPMC11297672</accession><cross_references><pubmed>38866091</pubmed><doi>10.1016/j.jmb.2024.168650</doi></cross_references></HashMap>